Impact of pregnancy on the outcomes of childbearing age women with chronic myeloid leukemia

Fernanda Maria Santos^{1

2}, Giovanna Ghelfond², Fernanda Salles Seguro^{1

2

3}, Andre Neder R Abdo^{1

2}, Thales Dalessandro^{1

2}, Felipe Vieira R Maciel^{1

2}, Lucas Bassolli², Vanderson Rocha^{1

2

3

4}, Israel Bendit^{2

3}

Affiliations

¹ Instituto do Cancer do Estado de Sao Paulo (ICESP), Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil.
² Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil.
³ Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil.
⁴ Churchill Hospital, Oxford University, Oxford, UK.

Free article

Fernanda Maria Santos et al. Am J Hematol. 2022.

Free article

. 2022 Feb 1;97(2):E72-E74.

doi: 10.1002/ajh.26424. Epub 2021 Nov 30.

¹ Instituto do Cancer do Estado de Sao Paulo (ICESP), Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil.
² Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil.
³ Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil.
⁴ Churchill Hospital, Oxford University, Oxford, UK.

No abstract available

References

1. Lasica M, Willcox A, Burbury K, et al. The effect of tyrosine kinase inhibitor interruption and interferon use on pregnancy outcomes and long-term disease control in chronic myeloid leukemia. Leuk Lymphoma. 2019;60(7):1796-1802. doi:10.1080/10428194.2018.1551533
1. Chen TC, Chen LC, Bin HY, Chang CS. Imatinib adherence associated clinical outcomes of chronic myeloid leukaemia treatment in Taiwan. Int J Clin Pharm. 2014;36(1):172-181. doi:10.1007/s11096-013-9876-7
1. Abruzzese E, Elena C, Castagnetti F, Gambacorti-Passerini C, Annunziata M, Luciano LM. Gimema registry of conception/pregnancy in adult Italian patients diagnosed with chronic myeloid leukemia (CML): report on 166 outcomes. Blood. 2018;132(supp 1):43. doi:10.1182/blood-2018-99-118908
1. Prager S, Dalton VK, Allen R. Clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol. 2018;132(5):e197-e207.
1. Cole S, Kantarjian H, Ault P, Cortés JE. Successful completion of pregnancy in a patient with chronic myeloid leukemia without active intervention: a case report and review of the literature. Clin Lymphoma Myeloma. 2009;9(4):324-327. doi:10.3816/CLM.2009.n.064